DEVELOPMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL PROGRAMS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sector of biopharmaceuticals, offering promising enhancements across different healthcare and industrial apps. With its structural similarity to Obviously derived human serum albumin, OsrHSA presents a safer, additional responsible alternate for therapeutic use, notab